Allevion Medical announced the FDA 510(k) clearance of Vantage, a fully disposable, sterile system designed to simplify and enhance minimally invasive lumbar decompression procedures associated with hypertrophic bone growth.

According to the company press release, Vantage enables targeted decompression through a patented approach that combines precision with procedural control. The structured approach supports procedural safety while enabling surgeons to efficiently remove hypertrophic bone from the lamina and facet joints that may contribute to spinal canal narrowing.

Traditional decompression procedures often require larger incisions and bulky instrumentation to retract tissue, which may increase the risk of scar tissue formation, prolonged recovery, and chronic pain.

A key differentiator of Vantage, says the company, is its direct visualization capability, supported by single use integrated illumination that allows physicians to visualize the targeted anatomy throughout the procedure. This feature enhances procedural control while supporting greater precision and safety.

Key highlights of Vantage include:

• Fully disposable, sterile system requiring no additional instruments or sterile processing
• Reproducible, step-based workflow designed to support procedural safety and efficiency
• Minimally invasive approach designed to limit tissue disruption
• Precision tools engineered for depth-controlled bone resection
• Single use integrated illumination enabling direct visualization of the surgical site
• Protective guards designed to help reduce the risk of damage to delicate structures